These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 1316069

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Leroy A, Fillastre JP, Humbert G.
    Antimicrob Agents Chemother; 1990 Jan; 34(1):17-20. PubMed ID: 2327756
    [Abstract] [Full Text] [Related]

  • 5. Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis.
    Triger DR, Granai F, Woodcock J, Wise R, Imbimbo BP.
    Hepatology; 1993 Oct; 18(4):847-52. PubMed ID: 8406358
    [Abstract] [Full Text] [Related]

  • 6. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA.
    Am J Med; 1992 Apr 06; 92(4A):18S-21S. PubMed ID: 1316065
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of temafloxacin in patients with liver impairment.
    Granneman GR, Mahr G, Locke C, Nickel P, Kirch W, Fabian W, Kinzig M, Naber KG, Sörgel F.
    Clin Pharmacokinet; 1992 Apr 06; 22 Suppl 1():24-32. PubMed ID: 1319868
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and safety of single oral doses of lomefloxacin.
    Morse IS.
    Biopharm Drug Dispos; 1990 Apr 06; 11(6):543-51. PubMed ID: 2207304
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lomefloxacin clinical pharmacokinetics.
    Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH.
    Clin Pharmacokinet; 1993 Jul 06; 25(1):6-19. PubMed ID: 8394795
    [Abstract] [Full Text] [Related]

  • 14. Renal clearance of lomefloxacin is decreased by furosemide.
    Sudoh T, Fujimura A, Shiga T, Sasaki M, Harada K, Tateishi T, Ohashi K, Ebihara A.
    Eur J Clin Pharmacol; 1994 Jul 06; 46(3):267-9. PubMed ID: 8070509
    [Abstract] [Full Text] [Related]

  • 15. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
    Wijnands GJ, Cornel JH, Martea M, Vree TB.
    Chest; 1990 Dec 06; 98(6):1440-4. PubMed ID: 2245687
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Highperformance liquid chromatographic assay for lomefloxacin in plasma and its pharmacokinetics in healthy volunteers].
    Tan L, Xu DK, Diao Y, Yuan YS.
    Yao Xue Xue Bao; 1993 Dec 06; 28(4):286-9. PubMed ID: 8213172
    [Abstract] [Full Text] [Related]

  • 20. [Lomefloxacin pharmacokinetics in patients in the terminal stage of chronic renal insufficiency, undergoing treatment with programmed hemodialysis].
    Kolendo SE, Vorob'ev PA, Dvoretskiĭ LI, Izotova GN, Miagkov AV, Shvyreva GS, Iakovlev SV.
    Antibiot Khimioter; 1995 Mar 06; 40(3):47-51. PubMed ID: 7575015
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.